Long-term disability after initiation of platform versus high-efficacy disease-modifying therapy in relapsing-onset multiple sclerosis
Study Overview The research investigates the long-term disability outcomes associated with two distinct treatment approaches in patients diagnosed with relapsing-onset […]
